$XNCR News Article - Xencor to Present Initial Data from the Phase 1 Study of Tidutamab in Neuroendocrine Tumors at NANETS' Multidisciplinary NET Medical Virtual Symposium https://marketwirenews.com/news-releases/xenc...96604.html
My Twitter: WhyteStocks